Literature DB >> 23144589

A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Zhao Zhong Chong1, Yan Chen Shang, Shaohui Wang, Kenneth Maiese.   

Abstract

Neurodegenerative disorders lead to disability and death in a significant proportion of the world's population. However, many disorders of the nervous system remain with limited effective treatments. Kinase pathways in the nervous system that involve phosphoinositide 3-kinase (PI 3-K), protein kinase B (Akt), and the mammalian target of rapamycin (mTOR) offer exciting prospects for the understanding of neurodegenerative pathways and the development of new avenues of treatment. PI 3-K, Akt, and mTOR pathways are vital cellular components that determine cell fate during acute and chronic disorders, such as Huntington's disease, Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and trauma. Yet, the elaborate relationship among these kinases and the variable control of apoptosis and autophagy can lead to unanticipated biological and clinical outcomes. Crucial for the successful translation of PI 3-K, Akt, and mTOR into robust and safe clinical strategies will be the further elucidation of the complex roles that these kinase pathways hold in the nervous system.

Entities:  

Year:  2012        PMID: 23144589      PMCID: PMC3491909          DOI: 10.2217/fnl.12.72

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  166 in total

1.  The many facets of cell injury: angiogenesis to autophagy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-05       Impact factor: 1.990

Review 2.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 3.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

4.  Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma.

Authors:  Vaishali Kapoor; Maya M Zaharieva; Satya N Das; Martin R Berger
Journal:  Cancer Lett       Date:  2011-12-24       Impact factor: 8.679

5.  mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Elaine A Dunlop; Bilgen Ekim; Nicole E Maj; Andrew R Tee; Diane C Fingar
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

6.  Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.

Authors:  M Broe; C E Shepherd; E A Milward; G M Halliday
Journal:  Acta Neuropathol       Date:  2001-06       Impact factor: 17.088

7.  Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.

Authors:  Ming-Jen Lu; Yih-Sharng Chen; Ho-Shiang Huang; Ming-Chieh Ma
Journal:  Life Sci       Date:  2012-04-12       Impact factor: 5.037

8.  mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia.

Authors:  María Dolores Pastor; Isaac García-Yébenes; Noelia Fradejas; José Manuel Pérez-Ortiz; Silvia Mora-Lee; Pedro Tranque; María Angeles Moro; Mario Pende; Soledad Calvo
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

9.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

Authors:  J Chen; X F Zheng; E J Brown; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 10.  Mapping autophagy on to your metabolic radar.

Authors:  Eijiro Yamada; Rajat Singh
Journal:  Diabetes       Date:  2012-02       Impact factor: 9.461

View more
  34 in total

1.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

Review 2.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

Review 3.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 4.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

Review 5.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

6.  Aluminum-Induced Cognitive Impairment and PI3K/Akt/mTOR Signaling Pathway Involvement in Occupational Aluminum Workers.

Authors:  Nan Shang; Ping Zhang; Shuo Wang; Jianping Chen; Rong Fan; Jin Chen; Tao Huang; Yanhong Wang; Jeremy Duncan; Ling Zhang; Qiao Niu; Qinli Zhang
Journal:  Neurotox Res       Date:  2020-06-06       Impact factor: 3.911

7.  Neuroprotective effect of vildagliptin against cerebral ischemia in rats.

Authors:  Salma A El-Marasy; Rehab F Abdel-Rahman; Reham M Abd-Elsalam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-18       Impact factor: 3.000

Review 8.  Cutting through the complexities of mTOR for the treatment of stroke.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

9.  Rapamycin, Autophagy, and Alzheimer's Disease.

Authors:  Zhiyou Cai; Liang-Jun Yan
Journal:  J Biochem Pharmacol Res       Date:  2013-06

10.  Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.

Authors:  Yan Chen Shang; Zhao Zhong Chong; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2013-02       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.